PeDRA Pearls

222 Episodes

1. Publication Presentation: Care of Congenital Melanocytic Nevi in Newborns and Infants

   Published: 6/28/2022
2. Getting to Know You: Jillian Rork, MD

   Published: 6/16/2022
3. PeDRA at 2022 Society for Investigative Dermatology

   Published: 6/2/2022
4. Hidradenitis Suppurativa Points of Discussion - Episode 3: Should Pediatric Hidradenitis Suppurativa be Treated Aggressively?

   Published: 5/27/2022
5. Hidradenitis Suppurativa Points of Discussion - Episode 2: Should Pediatric Hidradenitis Suppurativa be Treated Aggressively?

   Published: 5/27/2022
6. Hidradenitis Suppurativa Points of Discussion - Episode 1: Should Pediatric Hidradenitis Suppurativa be Treated Aggressively?

   Published: 5/27/2022
7. Getting to Know You: Carrie Coughlin, MD, MPHS

   Published: 5/18/2022
8. Getting to Know You: PeDRA

   Published: 4/22/2022
9. Down Syndrome Points of Discussion - Episode 3: Should Immune Modulators be Prescribed for Skin Diseases in Children with Down Syndrome?

   Published: 4/6/2022
10. Down Syndrome Points of Discussion - Episode 2: Should Immune Modulators be Prescribed for Skin Diseases in Children with Down Syndrome?

    Published: 4/6/2022
11. Down Syndrome Subgroup Points of Discussion - Episode 1: Should Immune Modulators be Prescribed for Skin Diseases in Children with Down Syndrome?

    Published: 4/6/2022
12. Getting to Know You: Harper Price, MD

    Published: 3/18/2022
13. Early Investigator Webinar: Imposter No More

    Published: 3/3/2022
14. New Advances in the Treatment of Atopic Dermatitis in Children

    Published: 3/2/2022
15. Getting to Know You: Megha Tollefson, MD

    Published: 2/16/2022
16. Atopic Dermatitis Points of Discussion - Episode 3: Should JAK Inhibitors be Considered for First-Line Therapy in the Treatment of AD in Children?

    Published: 1/31/2022
17. Atopic Dermatitis Points of Discussion - Episode 2: Should JAK Inhibitors be Considered for First-Line Therapy in the Treatment of AD in Children?

    Published: 1/31/2022
18. Atopic Dermatitis Points of Discussion - Episode 1: Should JAK Inhibitors be Considered for First-Line Therapy in the Treatment of AD in Children?

    Published: 1/31/2022
19. Getting to Know You: Beth Drolet, MD

    Published: 1/19/2022
20. Neonatal Skin Points of Discussion- Episode 3: Is Sunscreen Use Safe in Infants under 6 Months?

    Published: 12/30/2021